End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
95 TWD | -3.65% | +4.51% | +130.02% |
May. 13 | Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Easywell Biomedicals, Inc. announced a financing transaction | CI |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Development
100.0
%
| 179 | 100.0 % | 272 | 100.0 % | +51.90% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 179 | 100.0 % | 272 | 100.0 % | +51.90% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ai Ping Lee
CEO | Chief Executive Officer | - | 14-08-31 |
Hsueh Chun Wu
DFI | Director of Finance/CFO | - | - |
Howard Lee
BRD | Director/Board Member | 62 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jy Gang Ger
BRD | Director/Board Member | - | 16-06-22 |
Chih Cheng Chang
BRD | Director/Board Member | - | 13-10-24 |
Han Fei Lin
CHM | Chairman | - | - |
Howard Lee
BRD | Director/Board Member | 62 | - |
Chen Chung Chang
BRD | Director/Board Member | - | 03-06-24 |
Chi-Chow Liao
BRD | Director/Board Member | - | 13-10-24 |
Ai Ping Lee
CEO | Chief Executive Officer | - | 14-08-31 |
Tzu Cheng Chang
BRD | Director/Board Member | - | - |
Chao Long Chen
BRD | Director/Board Member | - | 22-06-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 121,866,000 | 53,103,775 ( 43.58 %) | 0 | 43.58 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+130.02% | 371M | |
+43.64% | 749B | |
+39.42% | 605B | |
-6.58% | 351B | |
+19.72% | 328B | |
+8.78% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.03% | 167B | |
+6.13% | 165B |
- Stock Market
- Equities
- 1799 Stock
- Company Easywell Biomedicals, Inc.